Skip to main content

Guinovart explains the IRB’s unique interdisciplinary characteristics to pharma executives

Images

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

The Pharma Boardroom is the premier website for senior executives, consultants, regulators and vendors working in Healthcare Life Sciences globally. Pharma Boardroom published today an interview with Joan Guinovart, the director of the IRB Barcelona. In it he discusses the Institute’s unique interdisciplinary characteristics and emphasizes the need for Spain to foster technology transfer as a means to further innovation.

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).